Antengene Corporation Limited (SEHK: 6996) presented preclinical data for its experimental autoimmune disease treatment ATG-207 at the European Congress of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE